Failure of exogenous insulin to inhibit insulin secretion in man. 1977

K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui

In order to explore whether or not the negative feedback mechanism of insulin per se on insulin secretion exists in man, changes in plasma C-peptide immunoreactivity (CPR), as an index of pancreatic B cells secretory function, were studied in 6 nonobese healthy volunteers in the presence of high circulating levels of exogenous insulin. 10% glucose was infused concurrently so as to maintain blood sugar at the basal level. The insulin-glucose infusion was maintained for 120 minutes, achieving mean plasma levels of 140-180 mu1/ml. After this period, the insulin infusion was continued at the same rate for an additional 10 minutes while the glucose was omitted. Despite the elevated level of circulating insulin, no significant change in plasma CPR concentration was observed so long as the blood sugar was maintained at the basal levels. Following cessation of the glucose infusion, the plasma CPR levels declined with a decrease in blood sugar level. Under the conditions of the present study, no inhibitory effect of exogenous insulin on the secretory function of the B cells was noticed.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
July 1983, Acta endocrinologica,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
June 1980, Endocrinologia japonica,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
June 1972, Israel journal of medical sciences,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
May 1978, Diabetes,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
March 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
January 1974, Steroids and lipids research,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
June 1975, The Journal of clinical endocrinology and metabolism,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
June 1979, Minerva medica,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
September 1974, Proceedings of the Royal Society of Medicine,
K Shima, and S Morishta, and N Sawazaki, and R Tanaka, and S Tarui
March 1977, The Journal of endocrinology,
Copied contents to your clipboard!